Barclays raised the firm’s price target on Novozymes to DKK 400 from DKK 364 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVZMY:
- Novozymes price target raised to DKK 400 from DKK 350 at Deutsche Bank
- Novozymes upgraded to Neutral from Sell at UBS
- Novozymes upgraded to Overweight from Equal Weight at Barclays
- Novozymes upgraded to Buy from Hold at Deutsche Bank
- Novozymes price target lowered to DKK 330 from DKK 360 at Barclays
